Profile
Susan Doleman is currently the Vice President-Clinical Operations at Cyteir Therapeutics, Inc. She previously worked as the Senior Director-Clinical Operations at Epizyme, Inc., a Scientist at The Children's Hospital Corp., and the Vice President-Clinical Development Operations at Replimune Group, Inc. Ms. Doleman received her undergraduate degree from Smith College.
Susan Doleman active positions
| Companies | Position | Start |
|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/07/2019 |
Former positions of Susan Doleman
| Companies | Position | End |
|---|---|---|
| EPIZYME, INC. | Chief Tech/Sci/R&D Officer | - |
The Children's Hospital Corp.
The Children's Hospital Corp. Hospital/Nursing ManagementHealth Services Operates pediatric hospitals | Chief Tech/Sci/R&D Officer | - |
| REPLIMUNE GROUP, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Susan Doleman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Smith College
Smith College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Children's Hospital Corp.
The Children's Hospital Corp. Hospital/Nursing ManagementHealth Services Operates pediatric hospitals | Health Services |
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Replimune Group, Inc.
Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Cyteir Therapeutics, Inc.
Cyteir Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology company | Health Technology |
- Stock Market
- Insiders
- Susan Doleman
















